Search

Author/Creator Munugalavadla, Veerendra

1. A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum‐resistant metastatic urothelial cancer. Issue 20 (5th August 2020)

Authors:
Zhang, Tian; Harrison, Michael R.; O'Donnell, Peter H.; Alva, Ajjai S.; Hahn, Noah M.; Appleman, Leonard J.; Cetnar, Jeremy; Burke, John M.; Fleming, Mark T.; Milowsky, Matthew I.; Mortazavi, Amir; Shore, Neal; Sonpavde, Guru P.; Schmidt, Emmett V.; Bitman, Bojena; Munugalavadla, Veerendra; Izumi...
Journal:
Cancer
Issue:
Volume 126:Issue 20(2020)
Page Start:
4485
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial. Issue 10232 (18th April 2020)

Authors:
Sharman, Jeff P; Egyed, Miklos; Jurczak, Wojciech; Skarbnik, Alan; Pagel, John M; Flinn, Ian W; Kamdar, Manali; Munir, Talha; Walewska, Renata; Corbett, Gillian; Fogliatto, Laura Maria; Herishanu, Yair; Banerji, Versha; Coutre, Steven; Follows, George; Walker, Patricia; Karlsson, Karin; Ghia, Pao...
Journal:
Lancet
Issue:
Volume 395:Issue 10232(2020)
Page Start:
1278
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Bioavailability of acalabrutinib suspension delivered via nasogastric tube in the presence or absence of a proton pump inhibitor in healthy subjects. Issue 10 (25th May 2022)

Authors:
Sharma, Shringi; Pepin, Xavier; Cheung, Jean; Zheng, Lianqing; Wei, Hua; Townsley, Danielle; Han, David; Majewski, Michal; Ware, Joseph A.; Mann, James; Munugalavadla, Veerendra; Sheridan, Louise; Patel, Priti; Gupta, Ashok; Tomkinson, Helen
Other Names:
Gacia‐Bournissen Facundo guestEditor.; Rieder Michael guestEditor.
Journal:
British journal of clinical pharmacology
Issue:
Volume 88:Issue 10(2022)
Page Start:
4573
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton‐Pump Inhibitors. Issue 11 (27th August 2022)

Authors:
Sharma, Shringi; Pepin, Xavier; Burri, Harini; Zheng, Lianqing; Kuptsova‐Clarkson, Nataliya; de Jong, Anouk; Yu, Ting; MacArthur, Holly L.; Majewski, Michal; Byrd, John C.; Furman, Richard R.; Ware, Joseph A.; Mann, James; Ramies, David; Munugalavadla, Veerendra; Sheridan, Louise; Tomkinson, Helen
Journal:
Clinical pharmacology in drug development
Issue:
Volume 11:Issue 11(2022)
Page Start:
1294
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Idelalisib reduces regulatory T cells and activates T helper 17 cell differentiation in relapsed refractory patients with chronic lymphocytic leukaemia. (15th February 2022)

Authors:
Gadi, Deepti; Griffith, Alec; Wang, Zixu; Tyekucheva, Svitlana; Rai, Vanessa; Fernandes, Stacey M.; Machado, John‐Hanson; Munugalavadla, Veerendra; Lederer, James; Brown, Jennifer R.
Journal:
British journal of haematology
Issue:
Volume 197:Number 2(2022)
Page Start:
207
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Pathological assessment of gastrointestinal biopsies from patients with idelalisib-associated diarrhea and colitis. (23rd March 2018)

Authors:
Yeung, Cecilia CS; Hockenbery, David M; Westerhoff, Maria; Coutre, Steven E; Sedlak, Ruth H; Dubowy, Ronald L; Munugalavadla, Veerendra; Taylor, Kerry; Bosch, Francesc
Journal:
Future oncology
Issue:
Volume 14:Number 22(2018)
Page Start:
2265
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer. Issue 1 (28th February 2020)

Authors:
Overman, Michael; Javle, Milind; Davis, Richard E; Vats, Pankaj; Kumar-Sinha, Chandan; Xiao, Lianchun; Mettu, Niharika B; Parra, Edwin R; Benson, Al B; Lopez, Charles D; Munugalavadla, Veerendra; Patel, Priti; Tao, Lin; Neelapu, Sattva; Maitra, Anirban
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗